Popular Articles

Research Says Modern Work-Related Stress Damages National Output More Than 1970s Strikes
Research presented by Bernard Casey of the University of Warwick"s Institute for Employment Research shows that work-related stress today damages national output even more than the loss to national output due to strikes at the peak of industrial unrest in the 1970s.
generic viagra online
Study Challenges Routine Use Of MRI Scans To Evaluate Breast Cancer
Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. The study demonstrates that, despite the lack of evidence of their benefit, routine use of MRI scans in women newly diagnosed with breast cancer increased significantly between 2004 and 2005, and again in 2006.
News of the day
Age Concern And Help The Aged On New Research On Dementia, UK
Commenting on the new research on Alzheimer"s by the the Institute of Psychiatry at King"s College London, Michelle Mitchell, Charity Director for Age Concern and Help the Aged said:
Mental Health

Merck & Co., Inc. Statement On Medicare Part D Assistance

Merck & Co., Inc. said it supports a proposal to provide additional assistance to Medicare Part D beneficiaries who have reached the coverage gap (donut hole) in their prescription benefit. Merck has a history of working to increase access to affordable health care and prescription drug coverage. In 2006, Merck supported the creation of the Medicare Part D program and continues to support its design and mission. Since its introduction, the Medicare Part D program has shown that beneficiaries" access to medicines has greatly improved and they are saving money. However, the dynamics of the Medicare Part D coverage gap have created some instability in the benefit for the consumer. Providing additional assistance in the coverage gap supports the success of the Medicare Part D program and mitigates cost hurdles for Medicare patients that can lead to lack of treatment adherence. "Our goal is to make sure that every patient who has been prescribed a Merck medicine has access to that medicine," said Richard T. Clark, chairman, president and CEO of Merck. "Merck has been providing free medicines to Medicare Part D beneficiaries through our Patient Assistance Programs for many years. With this new proposal we will go the extra step and offer direct savings to Medicare Part D beneficiaries in the coverage gap regardless of their income." Merck Expands Patient Assistance Programs The Merck Patient Assistance Program remains unchanged; it can provide free medicines to certain Medicare beneficiaries who have trouble affording their medicines. In March, the company increased the number of people who may benefit from the Merck Patient Assistance Program by raising the amount of income potential patients can earn and still qualify to receive Merck medicines for free. Patients in the United States now may be eligible for the program if their household income is at or below 400 percent of the Federal Poverty Level (FPL), which is set by the U.S. government and they are uninsured or otherwise unable to afford their medicines. This means that patients now qualify if they have a household income of $43,320 or less for individuals, $58,280 or less for couples, or $88,200 or less for a family of four, even if the financial situation is temporary due to unemployment or other reasons. Previously, patients were eligible if they were 200 percent or below FPL, which currently is $21,660, $29,140 and $44,100Āš, respectively. The Merck Patient Assistance Program is one of the oldest and most generous assistance programs in the industry. Over the past seven years, Merck has provided more than 1.7 million prescriptions to patients through the Merck Patient Assistance Program, at a value of $1.9 billion. For more information on Merck"s patient assistance programs visit: visit http://www.MerckHelps.com or call (800) PAP-5400. Merck


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):